EA202092566A1 - FACTOR IX POLYPEPTIDES AND METHODS OF THEIR USE - Google Patents

FACTOR IX POLYPEPTIDES AND METHODS OF THEIR USE

Info

Publication number
EA202092566A1
EA202092566A1 EA202092566A EA202092566A EA202092566A1 EA 202092566 A1 EA202092566 A1 EA 202092566A1 EA 202092566 A EA202092566 A EA 202092566A EA 202092566 A EA202092566 A EA 202092566A EA 202092566 A1 EA202092566 A1 EA 202092566A1
Authority
EA
Eurasian Patent Office
Prior art keywords
factor
polypeptides
methods
chimeric
hybrid
Prior art date
Application number
EA202092566A
Other languages
Russian (ru)
Inventor
Гленн Пирс
Саманта Трюкс
Роберт Т. Питерс
Хайянь Цзян
Original Assignee
Биовератив Терапьютикс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биовератив Терапьютикс Инк. filed Critical Биовератив Терапьютикс Инк.
Publication of EA202092566A1 publication Critical patent/EA202092566A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение представляет способы введения фактора IX; способы введения химерных и гибридных полипептидов, содержащих фактор IX; химерные и гибридные полипептиды, содержащие фактор IX; полинуклеотиды, кодирующие такие химерные и гибридные полипептиды; клетки, содержащие такие полинуклеотиды; и способы производства таких химерных и гибридных полипептидов с использованием таких клеток.The invention provides methods for administering factor IX; methods of administering chimeric and hybrid factor IX polypeptides; chimeric and hybrid polypeptides containing factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells containing such polynucleotides; and methods for the production of such chimeric and hybrid polypeptides using such cells.

EA202092566A 2011-04-01 2011-07-11 FACTOR IX POLYPEPTIDES AND METHODS OF THEIR USE EA202092566A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161470951P 2011-04-01 2011-04-01

Publications (1)

Publication Number Publication Date
EA202092566A1 true EA202092566A1 (en) 2021-11-30

Family

ID=78768163

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092566A EA202092566A1 (en) 2011-04-01 2011-07-11 FACTOR IX POLYPEPTIDES AND METHODS OF THEIR USE

Country Status (1)

Country Link
EA (1) EA202092566A1 (en)

Similar Documents

Publication Publication Date Title
EA201291480A1 (en) FACTOR IX POLYPEPTIDES AND METHODS FOR THEIR USE
EA201490039A1 (en) CHEMERIC AND HYBRID POLYPEPTIDES OF FACTOR VIII AND METHODS OF THEIR APPLICATION
MX2018012166A (en) Oral dosing of glp-1 compounds.
EA201691109A1 (en) CHEMERIC AND HYBRID POLYPEPTIDES OF VIII-FC FACTOR AND METHODS OF THEIR APPLICATION
MX2019000643A (en) Chimeric antigen receptors and methods for use.
MX2013015311A (en) Pcsk9-binding polypeptides and methods of use.
EA201590993A1 (en) HETERODIMERNY IMMUNOHLOBULINS
IN2015DN03029A (en)
MX346375B (en) Spiro-oxindole mdm2 antagonists.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
EA201400964A1 (en) CX3CR1-BONDING POLYPEPTIDES
UY34527A (en) ? COMPOSITIONS, METHODS AND KITS FOR THE PREPARATION OF SEALED RECOMBINING PROTEINS ?.
MX358864B (en) Chimeric antibacterial polypeptides.
MX365403B (en) Peptides and methods of using same.
EA201400339A1 (en) NEW IMIDAZOLAMINES AS MODULATORS OF KYNASE ACTIVITY
EA201690992A1 (en) ANTIBODIES SPECIFIC TO FCRN
EA201390955A1 (en) ROBO1-FC fusion protein for use in the treatment of hepatocarcinoma
MX362393B (en) Expression cassette.
EA202092566A1 (en) FACTOR IX POLYPEPTIDES AND METHODS OF THEIR USE
PH12014502182A1 (en) Methods and compositions for modulating notch activity
TN2013000202A1 (en) Spiro-oxindole mdm2 antagonists
UA72478U (en) Use of polentar as frigoprotector
TH135640B (en) Process for the manufacture of electrodes using oxygen